Docetaxel resistance-derived LINC01085 contributes to the immunotherapy of hormone-independent prostate cancer by activating the STING/MAVS signaling pathway-Reference-Cited by-同舟云学术

Docetaxel resistance-derived LINC01085 contributes to the immunotherapy of hormone-independent prostate cancer by activating the STING/MAVS signaling pathway

Published:2022-10 Issue: Volume:545 Page:215829
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Zhang Jiwei,Li Shengli^ORCID,Zhang Jianian,Zhang Wen,Jiang Jiawen,Wu Hao,Wu Enjiang,Feng Yutao^ORCID,Yang Li,Li Zhe^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference52 articles.

1. Recent global patterns in prostate cancer incidence and mortality rates;30207593Culp;Eur. Urol.,2020

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA A Cancer J. Clin.,2018

3. Hormonal therapy or chemotherapy for metastatic prostate cancer - playing the right CARD;Eisenberger;N. Engl. J. Med.,2019

4. Docetaxel activity in the era of life-prolonging hormonal therapies for metastatic castration-resistant prostate cancer;Francini;Eur. Urol.,2016

5. Docetaxel-based combination therapy for castration-resistant prostate cancer;Galsky;Ann. Oncol. : official journal of the European Society for Medical Oncology,2010

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pre-existing cell subpopulations in primary prostate cancer tumors display surface fingerprints of docetaxel-resistant cells;Cellular Oncology;2024-08-20

2. Transcriptomic analysis reveals regulation of adipogenesis via long non-coding RNA, alternative splicing, and alternative polyadenylation;Scientific Reports;2024-07-23

3. Epigenetic activation of METTL14 promotes docetaxel resistance in prostate cancer by promoting pri‐microRNA‐129 maturation;Environmental Toxicology;2024-03-28

4. The roles and molecular mechanisms of non-coding RNA in cancer metabolic reprogramming;Cancer Cell International;2024-01-18

5. The potential applications of artificially modified exosomes derived from mesenchymal stem cells in tumor therapy;Frontiers in Oncology;2024-01-04